Profound Medical Corp. (PROF) stock
PROFNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$7.42−0.02 (-0.27%)
Close on Nov 13, 2026Market cap $271.07MP/E –Yield –
Profound Medical pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Profound Medical's pe ratio was 4.8× on Jan 31, 2025, against 6.5× a year earlier. Over the last 5 years it ranged from 2.7× to 19.1×, with a median of 7.9×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Jan 31, 2025 | 4.8× | −0.8 |
| 2024 | Dec 31, 2024 | 5.6× | −0.5 |
| 2023 | Dec 29, 2023 | 6.2× | −1.1 |
| 2022 | Dec 30, 2022 | 7.3× | −1.7 |
| 2021 | Dec 31, 2021 | 9.0× | −6.0 |
| 2020 | Dec 31, 2020 | 15.0× | – |
See a number that looks wrong?